MTOR and Merkel cell skin cancer: Moreover, mutations in PI3K and its downstream molecules AKT and mTOR have been detected in more than 50% of MCC tumors, and activation of the PI3K/mTOR pathway is observed in up to 80% of all MCCs, subverting the normal requirement for cell proliferation [16,17,18,47,62].